These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 16114108)

  • 1. Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection.
    Guglietta S; Garbuglia AR; Pacciani V; Scottà C; Perrone MP; Laurenti L; Spada E; Mele A; Capobianchi MR; Taliani G; Folgori A; Vitelli A; Ruggeri L; Nicosia A; Piccolella E; Del Porto P
    Eur J Immunol; 2005 Sep; 35(9):2627-37. PubMed ID: 16114108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation between viral fitness and immune escape within the hepatitis C virus protease.
    Söderholm J; Ahlén G; Kaul A; Frelin L; Alheim M; Barnfield C; Liljeström P; Weiland O; Milich DR; Bartenschlager R; Sällberg M
    Gut; 2006 Feb; 55(2):266-74. PubMed ID: 16105887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of viral selected mutations on T cell mediated immunity in chronically evolving and self limiting acute HCV infection.
    Guglietta S; Garbuglia AR; Salichos L; Ruggeri L; Folgori A; Perrone MP; Camperio C; Mellace V; Maio G; Maio P; Capobianchi MR; Spada E; Gargano N; Scottà C; Piccolella E; Del Porto P
    Virology; 2009 Apr; 386(2):398-406. PubMed ID: 19232664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073.
    Fytili P; Dalekos GN; Schlaphoff V; Suneetha PV; Sarrazin C; Zauner W; Zachou K; Berg T; Manns MP; Klade CS; Cornberg M; Wedemeyer H
    Vaccine; 2008 Jul; 26(31):3818-26. PubMed ID: 18582999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
    J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in immunodominant T cell epitopes derived from the nonstructural 3 protein of hepatitis C virus have the potential for generating escape variants that may have important consequences for T cell recognition.
    Wang H; Eckels DD
    J Immunol; 1999 Apr; 162(7):4177-83. PubMed ID: 10201944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution.
    Neumann-Haefelin C; McKiernan S; Ward S; Viazov S; Spangenberg HC; Killinger T; Baumert TF; Nazarova N; Sheridan I; Pybus O; von Weizsäcker F; Roggendorf M; Kelleher D; Klenerman P; Blum HE; Thimme R
    Hepatology; 2006 Mar; 43(3):563-72. PubMed ID: 16496339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
    Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
    J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A HLA-A2-restricted-CTL epitope variation at the N-terminal of HCV helicase and the immune response of CTLs].
    Guo HZ; Wang WL; Wang T
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):325-7. PubMed ID: 15193229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal mapping of protective CD4+ T cell responses against HCV: analysis of fluctuating dominant and subdominant HLA-DR11 restricted epitopes.
    Harcourt GC; Lucas M; Sheridan I; Barnes E; Phillips R; Klenerman P
    J Viral Hepat; 2004 Jul; 11(4):324-31. PubMed ID: 15230855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection.
    Allen TM; Altfeld M; Yu XG; O'Sullivan KM; Lichterfeld M; Le Gall S; John M; Mothe BR; Lee PK; Kalife ET; Cohen DE; Freedberg KA; Strick DA; Johnston MN; Sette A; Rosenberg ES; Mallal SA; Goulder PJ; Brander C; Walker BD
    J Virol; 2004 Jul; 78(13):7069-78. PubMed ID: 15194783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C.
    Erickson AL; Houghton M; Choo QL; Weiner AJ; Ralston R; Muchmore E; Walker CM
    J Immunol; 1993 Oct; 151(8):4189-99. PubMed ID: 7691940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection.
    Bull RA; Leung P; Gaudieri S; Deshpande P; Cameron B; Walker M; Chopra A; Lloyd AR; Luciani F
    J Virol; 2015 May; 89(10):5478-90. PubMed ID: 25740982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCV persistence and immune evasion in the absence of memory T cell help.
    Grakoui A; Shoukry NH; Woollard DJ; Han JH; Hanson HL; Ghrayeb J; Murthy KK; Rice CM; Walker CM
    Science; 2003 Oct; 302(5645):659-62. PubMed ID: 14576438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen.
    Martin P; Parroche P; Chatel L; Barretto C; Beck A; Trépo C; Bain C; Lone YC; Inchauspé G; Fournillier A
    J Med Virol; 2004 Nov; 74(3):397-405. PubMed ID: 15368525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus mutation affects proteasomal epitope processing.
    Seifert U; Liermann H; Racanelli V; Halenius A; Wiese M; Wedemeyer H; Ruppert T; Rispeter K; Henklein P; Sijts A; Hengel H; Kloetzel PM; Rehermann B
    J Clin Invest; 2004 Jul; 114(2):250-9. PubMed ID: 15254592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
    Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
    J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and functional analysis of a conserved CTL epitope in HIV-1 p24 recognized from a long-term nonprogressor: constraints on immune escape associated with targeting a sequence essential for viral replication.
    Wagner R; Leschonsky B; Harrer E; Paulus C; Weber C; Walker BD; Buchbinder S; Wolf H; Kalden JR; Harrer T
    J Immunol; 1999 Mar; 162(6):3727-34. PubMed ID: 10092836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of cytotoxic T lymphocyte (CTL) escape mutations with persistent hepatitis C virus (HCV) infection.
    Weiner AJ; Erickson AL; Kansopon J; Crawford K; Muchmore E; Houghton M; Walker CM
    Princess Takamatsu Symp; 1995; 25():227-35. PubMed ID: 8875628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of T-cell responses against immunodominant epitopes from hepatitis C virus E2 and NS4a proteins.
    Sarobe P; Lasarte JJ; García N; Civeira MP; Borrás-Cuesta F; Prieto J
    J Viral Hepat; 2006 Jan; 13(1):47-55. PubMed ID: 16364082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.